For columnist Kristin Neva, whose husband, Todd, has ALS, everyday moments like her son's football game are filled with both ...

A man with ALS became the first person to control an Amazon Alexa with his thoughts via an implanted brain-computer interface ...

Certain rare genetic variants tied to Parkinson’s and other diseases raise the risk of developing ALS by more than three times, per a study.

Ractigen's therapy candidate RAG-17 was safe across all tested doses and showed early signs of effectiveness in SOD1-ALS ...

The Phase 1 clinical trial is expected to enroll about 60 participants to test how safe and well tolerated multiple doses of ...

Fourteen years into an ALS diagnosis, columnist Dagmar Munn decides in a visit to the dermatologist that she's earned her little skin bumps.

NRG Therapeutics will use a new grant to advance preclinical studies of its class of oral small molecules as a potential ...

AcuraStem has received $4 million in funding from the California Institute for Regenerative Medicine (CIRM) to advance the ...

The FDA has granted orphan drug status to Actimed Therapeutics' S-oxprenolol, a treatment candidate that aims to ease muscle ...

A strategy that simultaneously targets motor neurons, astrocytes, and microglia in ALS was found to extend survival in a ...

Measuring the levels of a novel protein biomarker called CXCL12 in the spinal fluid may improve the diagnosis of ALS, per a ...

Living with her late husband's ALS taught columnist Juliet Taylor valuable lessons about what strength and weakness really ...